Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus
Running, not enrolling · Phase 1 · Has a placebo group
Conditions studied: Normal Volunteers, Atopic Dermatitis (AD), Atopic Eczema, Chronic Pruritus
In brief
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic dermatitis and patients with chronic pruritus. The main questions it aims to answer are: What medical problems do participants have when taking ATTO-1310? How long does ATTO-1310 stay in the body after dosing? Researchers will compare ATTO-1310 to a placebo (a look-alike substance that contains no drug). Participants will be dosed with ATTO-1310 or a placebo, visit the clinic for checkups and tests, and keep a diary of their symptoms.
Key facts
- Study ID
- NCT06787586
- Run by
- Attovia Therapeutics Inc
- People needed
- 108
- Starts
- 2025-01-14
- Expected to finish
- 2026-05-01
- Last updated by the study team
- 2026-03-05
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
Where it is running
- Attovia Clinical Site 103 — Encinitas, California, United States
- Attovia Clinical Site 116 — Rocklin, California, United States
- Attovia Clinical Site 107 — Sacramento, California, United States
- Attovia Clinical Site 109 — Coral Gables, Florida, United States
- Attovia Clinical Site 118 — Margate, Florida, United States
- Attovia Clinical Site 102 — Plainfield, Indiana, United States
- Attovia Clinical Site 104 — Saint Joseph, Missouri, United States
- Attovia Clinical Site 106 — Reno, Nevada, United States
- Attovia Clinical Site 114 — New York, New York, United States
- Attovia Clinical Site 119 — New York, New York, United States
- Attovia Clinical Site 108 — San Antonio, Texas, United States
- Attovia Clinical Site 110 — Fredericton, New Brunswick, Canada
- Attovia Clinical Site 111 — Newmarket, Ontario, Canada
- Attovia Clinical Site 112 — Peterborough, Ontario, Canada
- Attovia Clinical Site 113 — Toronto, Ontario, Canada
- Attovia Clinical Site 105 — Montreal, Quebec, Canada
- Altasciences — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.